WaveMan
WaveMan · Company
CVSA · Covista Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CVSA Covista (CVSA) Insider Trading, Ownership & Congress Trades

Services · Services-educational services · CIK 0000730464
Quote by TradingView
Form 144 · 4
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
204
13F, latest reported quarter

What the filings say about CVSA

Insiders, 180 days
-$10.3M net sold
5 sellers · 18% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.8M
4 notices

Covista insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Covista Inc. insiders sold a net $10.3M of stock across 21 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Beard, Stephen W.
Chairman & CEO
SELL
2026-10-09 SEC
4,667
$610.3K
+2.1%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Oct 8, 2026.
  • The trade is 1.0% of the 469,158 shares held after it.
  • No other insider sold within 30 days.
  • 204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO Beard, Stephen W. sold about $610.3K of CVSA under a 10b5-1 plan on Oct 9, 2026; 204 funds added in the latest 13F quarter.
Beard, Stephen W.
Chairman & CEO
SELL
2026-10-09 SECtraded 2026-10-08
3,639
$474.4K
+2.1%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 11, 2026.
  • The trade is 0.8% of the 473,825 shares held after it.
  • No other insider sold within 30 days.
  • 204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO Beard, Stephen W. sold about $474.4K of CVSA under a 10b5-1 plan on Oct 8, 2026; 204 funds added in the latest 13F quarter.
Gangadharan Manjunath
VP, Chief Accounting Officer
SELL
2026-08-28 SECtraded 2026-08-27
1,802
$247.2K
-0.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 35.5% of the 5,083 shares held after it.
  • 3 other insiders sold within 30 days.
  • 204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Chief Accounting Officer Gangadharan Manjunath sold about $247.2K of CVSA under a 10b5-1 plan on Aug 27, 2026; 3 other insiders sold within 30 days and 204 funds added in the latest 13F quarter.
Beard, Stephen W.
Chairman & CEO
SELL
2026-08-13 SECtraded 2026-08-11
3,545
$462.1K
-0.3%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jul 13, 2026.
  • The trade is 0.9% of the 415,197 shares held after it.
  • 3 other insiders sold within 30 days.
  • 204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO Beard, Stephen W. sold about $462.1K of CVSA on Aug 11, 2026; 3 other insiders sold within 30 days and 204 funds added in the latest 13F quarter.
BECK DOUGLAS G.
SVP, GC, Corp. Sec & ISS
SELL
2026-08-11 SECtraded 2026-08-07
4,526
$614.7K
+2.6%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jul 8, 2026.
  • The trade is 15.9% of the 28,544 shares held after it.
  • 3 other insiders sold within 30 days.
  • 204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, GC, Corp. Sec & ISS BECK DOUGLAS G. sold about $614.7K of CVSA on Aug 7, 2026; 3 other insiders sold within 30 days and 204 funds added in the latest 13F quarter.
21 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 16 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$10.3M over 180 days
-$2.7M over 90 days
below 83% of Services
Congress
no House purchase disclosed in the last 12 months
Funds
204 funds bought in last quarter
more than 73% of Services
Revenue
+9.3% year over year
more than 61% of Services
Margin
12.9% net margin
more than 80% of Services
Buybacks
$239.9M repurchased, FY to 2026-06-30
more than 75% of Services
Short interest
7.7% of the float short (float per yahoo 2026-10-26) · 6.1 days to cover · settled 2026-09-30
more than 78% of Services
What changed in the last 30 days
Oct 9Chairman & CEO Beard, Stephen W. sold $1.1M under a 10b5-1 plan (2 trades, Oct 8 to Oct 9)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 9Director Stephen Beard filed to sell $603.8K by Oct 9 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 8Director Stephen Beard filed to sell $474.1K by Oct 8 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch CVSA

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-14.0%12M
-42%-28%-13%+1%2025-102025-122026-022026-042026-062026-082026-10 2026-05-08 · Beard, Stephen W. sold $2.1M2026-03-10 · MALAFRONTE MICHAEL W bought $1.5M2026-05-08 · Phelan Robert J. sold $1.3M2026-05-08 · BECK DOUGLAS G. sold $1.2M2026-03-10 · MALAFRONTE MICHAEL W bought $1.2M2026-03-11 · MALAFRONTE MICHAEL W bought $897.4K2026-07-13 · Beard, Stephen W. sold $702.4K2026-08-07 · BECK DOUGLAS G. sold $614.7K2026-10-09 · Beard, Stephen W. sold $610.3K2026-10-08 · Beard, Stephen W. sold $474.4K2026-08-11 · Beard, Stephen W. sold $462.1K2026-07-07 · Phelan Robert J. sold $392.7K2026-06-10 · Beard, Stephen W. sold $359.4K2026-07-07 · BECK DOUGLAS G. sold $358.8K2026-06-11 · Beard, Stephen W. sold $330.7K2026-07-08 · BECK DOUGLAS G. sold $330.1K2026-07-08 · Phelan Robert J. sold $326.8K2026-08-07 · Phelan Robert J. sold $295.4K2026-05-08 · Cox Karen Sue sold $249.0K2026-08-27 · Gangadharan Manjunath sold $247.2K2026-03-03 · MALAFRONTE MICHAEL W bought $117.6K2026-10-09 · Stephen Beard filed to sell $603.8K2026-10-08 · Stephen Beard filed to sell $474.1K2026-08-27 · MANJUNATH GANGADHARAN filed to sell $248.3K2026-08-11 · Stephen Beard filed to sell $448.4K2026-07-13 · Stephen Beard filed to sell $704.7K2026-07-07 · DOUGLAS BECK filed to sell $1.2M2026-07-07 · ROBERT PHELAN filed to sell $971.7K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CVSA: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
5,480,326 sh
$683.2M
FMR LLC
3,218,203 sh
$401.2M
VANGUARD PORTFOLIO MANAGEMENT LLC
2,386,958 sh
$297.6M
DIMENSIONAL FUND ADVISORS LP
1,782,750 sh
$222.2M
ARIEL INVESTMENTS, LLC
1,771,844 sh
$220.9M

Congress trades in CVSA

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CVSA planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Stephen Beard
Filed 2026-10-09
$603.8K
Stephen Beard
Filed 2026-10-08
$474.1K
MANJUNATH GANGADHARAN
Filed 2026-08-27
$248.3K
Stephen Beard
Filed 2026-08-11
$448.4K
Stephen Beard
Filed 2026-07-13
$704.7K

CVSA mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ariel Fund
$87.5M position · as of 2026-06-30
3.0%
CANTOR FITZGERALD EQUITY OPPORTUNITY FUND
$2.3M position · as of 2026-06-30
2.8%
Hartford Global Impact Fund
$9.2M position · as of 2026-07-31
2.6%
Schwab Ariel Opportunities ETF
$543.0K position · as of 2026-06-30
2.0%
VANGUARD EXPLORER VALUE FUND
$23.7M position · as of 2026-05-31
1.9%
Nationwide Renaissance Small Cap Growth Fund
$423.7K position · as of 2026-07-31
1.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Covista Inc. Political Action Committee (Covista Pac)
Cycle 2026 · $33K spent
$34.0K
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $10.3M sold by insiders over 180 days, 204 funds added last quarter, $1.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
DASHABNBSEETSYFICOXMTRACNZGFLYWMAMAXPHR

CVSA financials

Revenue growth
+9.3%
XBRL, annual
Net margin
12.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.0B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+12.9%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$392.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.46x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.71x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+17.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+8.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+16.5%
operating income after a 22.5% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+16.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
18.71x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$4.7B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+8.8%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
1.38x
P/E over trailing EPS growth of 14%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-062025-062024-062023-09
Revenue$2.0B$1.8B$1.6Bn/a
Operating income$383.4M$341.5M$217.1Mn/a
Net income$251.6M$237.1M$136.8Mn/a
EPS (diluted)7.046.183.39n/a
Operating cash flow$470.4M$337.9M$295.8Mn/a
Cash$406.3M$199.6M$219.3M$260.8M
Long-term debt$657.8M$552.7M$648.7Mn/a
Buybacks$239.9M$213.1M$262.0Mn/a
SEC XBRL, fiscal years, as known on 2026-10-28

CVSA Stock Sonar score 6/7 axes

Find similar shapesCompare

CVSA ranks highest on institutional and government (73rd percentile) and profitability (71st), and lowest on insider conviction (9th), among Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
71
Inputs
  • Return on equity+17.5% · 73 pct, sector of 207
  • Return on assets+8.7% · 81 pct, sector of 269
  • Return on invested capital+16.5% · 54 pct, sector of 81
  • Return on capital employed+16.5% · 77 pct, sector of 203
Financial health
61
Inputs
  • Debt to equity0.46x · 44 pct, sector of 228
  • Cash flow to debt0.71x · 78 pct, sector of 199
Growth
61
Inputs
  • Revenue growth, YoY+9.3% · 61 pct, sector of 341
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
9
Inputs
  • Net Form 4 buying (codes P and S), 180d-$9.0M · 17 pct, sector of 174
  • Insider buyers, 180d0 · 0 pct, sector of 179
Institutional and government
73
Inputs
  • Funds adding, latest quarter204 · 73 pct, sector of 243
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$1.9M · 73 pct, sector of 61
Risk and compliance
27
Inputs
  • Short interest, % of float+7.7% · 24 pct, sector of 383
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+16.5% · 30 pct, sector of 227
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CVSA filings, in plain words

Are Covista insiders buying or selling CVSA?

In the 180 days to 2026-10-28, Covista insiders were net sellers, a net $10.3M across purchases and sales reported on Form 4, by 5 sellers.

Are there planned insider sales of CVSA?

Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.8M of stock; the latest, by Stephen Beard, was filed 2026-10-09.

Read the full summary

In the 180 days to 2026-10-28, Covista insiders were net sellers of CVSA, a net $10.3M across purchases and sales reported on Form 4 by 5 sellers. 18% of the 17 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies